Alex Polozov

Research Areas

Inflammatory mediators and NSAID effects, Antiplatelet Therapy and Cardiovascular Diseases, Synthesis of β-Lactam Compounds

Most-Cited Works

• → Antagonists of the EP₃ Receptor for Prostaglandin E₂ Are Novel Antiplatelet Agents That Do Not Prolong Bleeding(2009)69 cited
• → Structure−Activity Relationship Studies Leading to the Identification of (2E)-3-[l-[(2,4-Dichlorophenyl)methyl]-5-fluoro-3-methyl-lH-indol-7-yl]-N-[(4,5-dichloro-2-thienyl)sulfonyl]-2-propenamide (DG-041), a Potent and Selective Prostanoid EP3 Receptor Antagonist, as a Novel Antiplatelet Agent That Does Not Prolong Bleeding(2009)41 cited